Products

Pure Human-Derived Stem Cell Factor Products

Two core product lines based on extracellular vesicle and cytokine technology: Pure Human-Derived Immune Stem Cell Factor Suspension (IV) and Human Umbilical Cord Mesenchymal Stem Cell Factor Suspension (subcutaneous). Both products are manufactured under Class II medical device standards with complete regulatory documentation.

Product Line 1: Pure Human-Derived Immune Stem Cell Factor Suspension

Administration: Intravenous (IV) infusion. Designed for immune system modulation and systemic research applications.

Product Specifications

6Vials per box
160BCytokines per vial
30-200nmParticle diameter
2-8°CCold-chain storage

Source Materials

Main ingredient: Newborn umbilical cord blood (research collaboration with Guangzhou Women and Children’s Medical Center)

Excipient: US-imported pure human serum (no animal serum, no fetal bovine serum)

Cell type: Mesenchymal stem cells induced toward immune T-cell direction, creating dual-function cells with both regenerative repair and immune killing capabilities

Manufacturing Process

Step 1: 3D bioreactor cultivation — simulate 260+ disease growth environments with precise temperature, humidity, and pH control

Step 2: Immune induction and purification — induce differentiation toward immune T-cell direction, then filter and 100% purify nano-scale cytokines

Step 3: Encapsulation, labeling, traceability code application, and quality inspection at Guangzhou Bio-Island facility

Safety Profile

Non-toxic and non-harmful: Free from toxic or harmful substances
Sterile: No viable microorganisms detected
Virus-free: No viral contamination
Endotoxin-free: Endotoxin levels within safe limits
Hormone-free: No hormonal substances
Allergen-free: Suitable for all body types
No immune rejection: No cell membrane, no MHC molecules
No tumor risk: No cell nucleus, no tumor promotion potential

Product Line 2: Human Umbilical Cord Mesenchymal Stem Cell Factor Suspension

Administration: Subcutaneous injection. Designed for localized regenerative and aesthetic research applications.

Key Features

100%Human-derived
Non-invasiveSubcutaneous admin
30-200nmNano-scale particles
Class IIMedical device

Cell Regeneration

Supports cellular renewal processes, skin age reversal, and tissue repair research.

Firming and Lifting

Research into skin tightening, elasticity improvement, and structural support.

Soothing and Anti-inflammatory

Research into sensitivity reduction, inflammation modulation, and skin calming.

Technology Comparison: Extracellular Vesicles vs. Traditional Cell Therapy

Our nano-scale cytokine platform addresses key limitations of traditional cell-based approaches.

Traditional Cell Therapy

  • Complete cells with membrane and nucleus
  • MHC molecules on cell membrane cause rejection
  • Large cells (10-100μm) cannot pass through lung tissue
  • Cell nucleus may promote cancer cell growth
  • Cannot penetrate blood-brain barrier
  • Varied source materials (autologous, animal serum)
  • Complex storage and transport requirements

Yanhua Bio Extracellular Vesicles

  • 100% purified nano-scale cytokines (no membrane, no nucleus)
  • No cell membrane — no immune rejection
  • Nano-scale particles (30-200nm) penetrate freely
  • No nucleus — no tumor promotion risk
  • Can penetrate blood-brain barrier
  • 100% human-derived (umbilical cord blood + human serum)
  • Stable 2-8°C cold-chain, easy storage and transport

Research Areas and Application Focus

Our 3D bioreactor technology enables disease-specific formulation development across multiple research areas. The following areas are for institutional discussion only and do not represent approved therapeutic claims.

Neurological Research

Parkinson’s Disease
Alzheimer’s Disease
Multiple System Atrophy
Neuron Diseases
Depression
Stroke Recovery

Immune Health Research

Subhealth Conditions
Frequent Infections
HPV
Thyroid Nodules
Immune Deficiency
Post-illness Recovery

Metabolic Research

Uric Acid / Gout
Diabetes Prevention
Metabolic Syndrome
Liver Support
Kidney Support

Women’s Health Research

Immune Infertility
Premature Ovarian Failure
Menopause Syndrome
Irregular Menstruation
Endometriosis
Postpartum Repair

Men’s Health Research

Prostate Diseases
Post-treatment Recovery
Sexual Function
Fatigue Recovery

Aesthetic and Anti-Aging Research

Cell Regeneration
Skin Age Reversal
Firming and Lifting
Soothing and Anti-inflammatory
Skin Brightening

Regulatory and Compliance

Medical Device Classification

Class: Class II Medical Device (械二类)

Production License: 粤穗食药监械生产备20210002号

Product Licenses: 粤穗械备20210011号, 粤穗械备20210009号

Operation License: 粤穗食药监械经营备20220325号

Registered Trademarks

研华 — Company brand trademark

GABT研华生物 — International brand trademark

胚泌 — Product line trademark

Important: Product availability, intended use, and clinical application depend on local regulatory status and approved protocols in each target country. Yanhua Bio’s China-based qualifications must be reviewed according to each country’s regulatory requirements before any local clinical, commercial, import, or promotional activity.

Request Product Documentation

For scientific, institutional, and partnership inquiries, our international team can share the appropriate technical materials.